SEC Form 4 · accession 0001209191-18-018326
HERBALIFE LTD. · HLF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shin-Shing Bosco Chiu
Officer — Principal Accounting Officer
Period of report
Mar 6, 2018
Accepted (ET)
Mar 8, 2018 · 7:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 6, 2018 | M | 15,396 | $59.98 | A | 17,278 | D | |
| Common Stock | Mar 6, 2018 | D | 9,538 | $96.84 | D | 7,740 | D | |
| Common Stock | Mar 6, 2018 | F | 2,908 | $96.84 | D | 4,832 | D | |
| Common Stock | Mar 6, 2018 | M | 18,760 | $30.44 | A | 23,592 | D | |
| Common Stock | Mar 6, 2018 | D | 5,899 | $96.84 | D | 17,693 | D | |
| Common Stock | Mar 6, 2018 | F | 6,379 | $96.84 | D | 11,314 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation Rights | $59.98 | Mar 6, 2018 | M | 15,396 | D | Apr 30, 2017 | Apr 30, 2024 | Common Stock | 15,396 | 0 | D |
| Stock Appreciation Rights | $30.44 | Mar 6, 2018 | M | 18,760 | D | Mar 2, 2018 | Mar 2, 2025 | Common Stock | 18,760 | 0 | D |
Explanation of responses
- F1The reporting person received 2,950 shares of common stock upon the net exercise of 15,396 stock appreciation rights ("SARS"). The reporting person forfeited 9,538 shares of common stock underlying the SARS in payment of the exercise price and 2,908 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on March 6, 2018 of $96.84.
- F2The reporting person received 6,482 shares of common stock upon the net exercise of 18,760 SARs. The reporting person forfeited 5,899 shares of common stock underlying the SARS in payment of the exercise price and 6,379 shares of common stock underlying the SARS to satisfy the withholding tax obligations resulting from the exercise, using the closing stock price on March 6, 2018 of $96.84.